|
1
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Karvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Potekaev NN, Zhukova OV, Protsenko DN,
Demina OM, Khlystova EA and Bogin V: Clinical characteristics of
dermatologic manifestations of COVID-19 infection: Case series of
15 patients, review of literature, and proposed etiological
classification. Int J Dermatol. 59:1000–1009. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gisondi P, Piaserico S, Conti A and Naldi
L: Dermatologists and SARS-CoV-2: The impact of the pandemic on
daily practice. J Eur Acad Dermatol Venereol. 34:1196–1201.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Recalcati S: Cutaneous manifestations in
COVID-19: A first perspective. J Eur Acad Dermatol Venereol.
34:e212–e213. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ahouach B, Harent S, Ullmer A, Martres P,
Bégon E, Blum L, Tess O and Bachmeyer C: Cutaneous lesions in a
patient with COVID-19: Are they related? Br J Dermatol.
183(e31)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iordache AM, Docea AO, Buga AM, Mitrut R,
Albulescu D, Zlatian O, Ianosi S, Ianosi G, Neagoe D, Sifaki M, et
al: The incidence of skin lesions in contrast media-induced
chemical hypersensitivity. Exp Ther Med. 17:1113–1124.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Martinez-Lopez A, Cuenca-Barrales C,
Montero-Vilchez T, Molina-Leyva A and Arias-Santiago S: Review of
adverse cutaneous reactions of pharmacologic interventions for
COVID-19: A guide for the dermatologist. J Am Acad Dermatol.
83:1738–1748. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mascitti H, Bonsang B, Dinh A, Assan F,
Perronne V, Leblanc T, Duran C, Bouchand F, Matt M, Le Gal A, et
al: Clinical cutaneous features of patients infected with
SARS-CoV-2 hospitalized for pneumonia: A cross-sectional study.
Open Forum Infect Dis. 7(ofaa394)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Le Cleach L, Dousset L, Assier H, Fourati
S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C,
Colin A, et al: Most chilblains observed during the COVID-19
outbreak occur in patients who are negative for COVID-19 on
polymerase chain reaction and serology testing. Br J Dermatol.
183:866–874. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Brănișteanu DE, Ianoşi SL, Dimitriu A,
Stoleriu G, Oanţǎ A and Brănișteanu DC: Drug-induced rowell
syndrome, a rare and difficult to manage disease: A case report.
Exp Ther Med. 15:785–788. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kaya G, Kaya A and Saurat JH: Clinical and
histopathological features and potential pathological mechanisms of
skin lesions in COVID-19: Review of the literature.
Dermatopathology (Basel). 7:3–16. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Genovese G, Moltrasio C, Berti E and
Marzano AV: Skin manifestations associated with COVID-19: Current
knowledge and future perspectives. Dermatology. 237:1–12.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Darlenski R and Tsankov N: COVID-19
pandemic and the skin: What should dermatologists know? Clin
Dermatol. 38:785–787. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Suchonwanit P, Leerunyakul K and
Kositkuljorn C: Cutaneous manifestations in COVID-19: Lessons
learned from current evidence. J Am Acad Dermatol. 83:e57–e60.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jimenez-Cauhe J, Ortega-Quijano D, de
Perosanz-Lobo D, Burgos-Blasco P, Vañó-Galván S, Fernandez-Guarino
M and Fernandez-Nieto D: Enanthem in patients with COVID-19 and
skin rash. JAMA Dermatol. 156:1134–1136. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rochefort J and Chaux AG: Oral mucosal
lesions and Covid-19: Symptoms and/or complication? J Oral Med Oral
Surg. 27(23)2021.
|
|
18
|
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J,
Liu L, Shan H, Lei C, Hui DSC, et al: Clinical characteristics of
coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.
|
|
19
|
Aida Maranduca M, Liliana Hurjui L,
Constantin Branisteanu D, Nicolae Serban D, Elena Branisteanu D,
Dima N and Lacramioara Serban I: Skin-a vast organ with
immunological function (Review). Exp Ther Med. 20:18–23.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hubiche T, Cardot-Leccia N, Le Duff F,
Seitz-Polski B, Giordana P, Chiaverini C, Giordanengo V, Gonfrier
G, Raimondi V, Bausset O, et al: Clinical, laboratory, and
interferon-alpha response characteristics of patients with
chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol.
157:202–206. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Galván Casas C, Català A, Carretero
Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D,
Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R,
Falkenhain-López D, Llamas Velasco M, et al: Classification of the
cutaneous manifestations of COVID-19: A rapid prospective
nationwide consensus study in Spain with 375 cases. Br J Dermatol.
183:71–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Marzano AV, Cassano N, Genovese G,
Moltrasio C and Vena GA: Cutaneous manifestations in patients with
COVID-19: A preliminary review of an emerging issue. Br J Dermatol.
183:431–442. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gisondi P, PIaserico S, Bordin C, Alaibac
M, Girolomoni G and Naldi L: Cutaneous manifestations of SARS-CoV-2
infection: A clinical update. J Eur Acad Dermatol Venereol.
34:2499–2504. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Freeman EE, McMahon DE, Lipoff JB,
Rosenbach M, Kovarik C, Desai SR, Harp J, Takeshita J, French LE,
Lim HW, et al: The spectrum of COVID-19-associated dermatologic
manifestations: An international registry of 716 patients from 31
countries. J Am Acad Dermatol. 83:1118–1129. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Seirafianpour F, Sodagar S, Pour Mohammad
A, Panahi P, Mozafarpoor S, Almasi S and Goodarzi A: Cutaneous
manifestations and considerations in COVID-19 pandemic: A
systematic review. Dermatol Ther. 33(e13986)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rodríguez-Jiménez P, Chicharro P, De
Argila D, Muñoz-Hernández P and Llamas-Velasco M: Urticaria-like
lesions in COVID-19 patients are not really urticaria-a case with
clinicopathological correlation. J Eur Acad Dermatol Venereol.
34:e459–e460. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Amatore F, Macagno N, Mailhe M, Demarez B,
Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P and Richard MA:
SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad
Dermatol Venereol. 34:e304–e306. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tan SW, Tam YC and Oh CC: Skin
manifestations of COVID-19: A worldwide review. JAAD Int.
2:119–133. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Usher AD: WHO launches crowdfund for
COVID-19 response. Lancet. 395(1024)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gianotti R, Recalcati S, Fantini F, Riva
C, Milani M, Dainese E and Boggio F: Histopathological study of a
broad spectrum of skin dermatoses in patients affected or highly
suspected of infection by COVID-19 in the Northern Part of Italy:
Analysis of the many faces of the viral-induced skin diseases in
previous and new reported cases. Am J Dermatopathol. 42:564–570.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Reymundo A, Fernáldez-Bernáldez A, Reolid
A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D,
Wiesner T and Llamas-Velasco M: Clinical and histological
characterization of late appearance maculopapular eruptions in
association with the coronavirus disease 2019. A case series of
seven patients. J Eur Acad Dermatol Venereol. 34:e755–e757.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Herrero-Moyano M, Capusan TM,
Andreu-Barasoain M, Alcántara-González Ruano-Del Salado M,
Sánchez-Largo Uceda ME, Calzado-Villarreal L and Pérez-González Y:
A clinicopathological study of eight patients with COVID-19
pneumonia and a late-onset exanthema. J Eur Acad Dermatol Venereol.
34:e460–e464. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Marzano AV, Genovese G, Fabbrocini G,
Pigatto P, Monfrecola G, Piraccini BM, Veraldi S, Rubegni P, Cusini
M, Caputo V, et al: Varicella-like exanthem as a specific
COVID-19-associated skin manifestation: Multicenter case series of
22 patients. J Am Acad Dermatol. 83:280–285. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tammaro A, Adebanjo GAR, Parisella FR,
Pezzuto A and Rello J: Cutaneous manifestations in COVID-19: The
experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol.
34:e306–e307. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mahé A, Birckel E, Merklen C, Lefèbvre P,
Hannedouche C, Jost M and Droy-Dupré L: Histology of skin lesions
establishes that the vesicular rash associated with COVID-19 is not
‘varicella-like’. J Eur Acad Dermatol Venereol. 34:e559–e561.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fernandez-Nieto D, Ortega-Quijano D,
Jimenez-Cauhe J, Burgos-Blasco P, de Perosanz-Lobo D, Suarez-Valle
A, Cortes-Cuevas JL, Carretero I, Garcia-Del Real C and
Fernandez-Guarino M: Clinical and histological characterization of
vesicular COVID-19 rashes: A prospective study in a tertiary care
hospitall. Clin Exp Dermatol. 45:872–875. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cappel MA, Cappel JA and Wetter DA: Pernio
(Chilblains), SARS-CoV-2, and COVID toes unified through cutaneous
and systemic mechanisms. Mayo Clin Proc. 96:989–1005.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hoenig LJ: Update on the cutaneous
manifestations of COVID-19. Clin Dermatol. 38(507)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bouaziz JD, Duong TA, Jachiet M, Velter C,
Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M,
Begon E, et al: Vascular skin symptoms in COVID-19: A French
observational study. J Eur Acad Dermatol Venereol. 34:e451–e452.
2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Guelimi R, Salle R, Dousset L, Assier H,
Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L,
Cazenave C, et al: Cutaneous manifestations during COVID-19
epidemic: COVID-skin study of the French society of dermatology.
Ann Dermatol Venereol. 147(A135)2020.doi.org/10.1016/j.annder.2020.09.116.
|
|
41
|
Magro C, Mulvey JJ, Berlin D, Nuovo G,
Salvatore S, Harp J, Baxter-Stoltzfus A and Laurence J: Complement
associated microvascular injury and thrombosis in the pathogenesis
of severe COVID-19 infection: A report of five cases. Transl Res.
220:1–13. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Alramthan A and Aldaraji W: Two cases of
COVID-19 presenting with a clinical picture resembling chilblains:
First report from the Middle East. Clin Exp Dermatol. 45:746–748.
2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Manalo IF, Smith MK, Cheeley J and Jacobs
R: A dermatologic manifestation of COVID-19: Transient livedo
reticularis. J Am Acad Dermatol. 83(700)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Joob B and Wiwanitkit V: COVID-19 can
present with a rash and be mistaken for dengue. J Am Acad Dermatol.
82(e177)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
European Centre for Disease Prevention and
Control: Paediatric inflammatory multisystem syndrome and
SARS-CoV-2 infection in children - May 15, 2020. ECDC, Stockholm,
2020.
|
|
46
|
Verdoni L, Mazza A, Gervasoni A, Martelli
L, Ruggeri M, Ciuffreda M, Bonanomi E and D'Antiga L: An outbreak
of severe Kawasaki-like disease at the Italian epicentre of the
SARS-CoV-2 epidemic: An observational cohort study. Lancet.
395:1771–1778. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Whittaker E, Bamford A, Kenny J, Kaforou
M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davis P, et
al: Clinical characteristics of 58 children with a pediatric
inflammatory multisystem syndrome temporally associated with
SARS-CoV-2. JAMA. 324:259–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Méndez-Flores S, Zaladonis A and
Valdes-Rodriguez R: COVID-19 and nail manifestation: Be on the
lookout for the red half-moon nail sign. Int J Dermatol.
59(1414)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Neri I, Guglielmo A, Virdi A, Gaspari V,
Starace M and Piraccini BM: The red half-moon nail sign: A novel
manifestation of coronavirus infection. J Eur Acad Dermatol
Venereol. 34:e663–e665. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Sacks EH, Wieczorek R, Jakobiec FA and
Knowles DM II: Lymphocytic subpopulations in the normal human
conjunctiva. A monoclonal antibody study. Ophthalmology.
93:1276–1283. 1986.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Rodrigues MM, Rowden G, Hackett J and
Bakos I: Langerhans cells in the normal conjunctiva and peripheral
cornea of selected species. Invest Ophthalmol Vis Sci. 21:759–765.
1981.PubMed/NCBI
|
|
52
|
Zhou L, Xu Z, Castiglione GM, Soiberman
US, Eberhart CG and Duh EJ: ACE2 and TMPRSS2 are expressed on the
human ocular surface, suggesting susceptibility to SARS-CoV-2
infection. Ocul Surf. 18:537–544. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang X, Chen X, Chen L, Deng C, Zou X,
Liu W, Yu H, Chen B and Sun X: The evidence of SARS-CoV-2 infection
on ocular surface. Ocul Surf. 18:360–362. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Loffredo L, Pacella F, Pacella E, Tiscione
G, Oliva A and Violi F: Conjunctivitis and COVID-19: A
meta-analysis. J Med Virol. 92:1413–1414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Salducci M and La Torre G: COVID-19
emergency in the cruise's ship: A case report of conjunctivitis.
Clin Ter. 171:e189–e191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Navel V, Chiambaretta F and Dutheil F:
Haemorrhagic conjunctivitis with pseudomembranous related to
SARS-CoV-2. Am J Ophthalmol Case Rep. 19(100735)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Cheema M, Aghazadeh H, Nazarali S, Ting A,
Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF and Solarte C:
Keratoconjunctivitis as the initial medical presentation of the
novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol.
55:e125–e129. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Sungnak W, Huang N, Bécavin C, Berg M,
Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D,
Sampaziotis F, et al: SARS-CoV-2 entry factors are highly expressed
in nasal epithelial cells together with innate immune genes. Nat
Med. 26:681–687. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Xia J, Tong J, Liu M, Shen Y and Guo D:
Evaluation of coronavirus in tears and conjunctival secretions of
patients with SARS-CoV-2 infection. J Med Virol. 92:589–594.
2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L
and Wu K: Characteristics of ocular findings of patients with
coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA
Ophthalmol. 138:575–578. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Su CJ and Lee CH: Viral exanthem in
COVID-19, a clinical enigma with biological significance. J Eur
Acad Dermatol Venereol. 34:e251–e252. 2020.PubMed/NCBI View Article : Google Scholar
|
